MCT for the Harvard/UCSF ROBIN Center
Conditions: Glioma, Childhood Brainstem; Neuroblastoma Interventions: Radiation: External beam radiotherapy; Radiation: 131I-Metaiodobenzylguanidine (MIBG) Sponsors: Brigham and Women's Hospital; Dana-Farber Cancer Institute; National Cancer Institute (NCI); University of California, San Francisco Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Brain | Brain Tumor | Cancer & Oncology | Glioma | Harvard | Hospitals | Neuroblastoma | Neurology | Research | Women